Duncan Mckechnie
Evp, Chief Commercial Officer at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 7SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,541 | $519.00 | $800K | -3.0% |
| Mar 13SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,633 | $498.42 | $1.3M | +1.0% |
| Mar 6SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,437 | $475.30 | $1.2M | +5.9% |
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,500 | $486.35 | $1.2M | +3.5% |
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,410 | $489.00 | $1.2M | +3.0% |
- Sell
Evp, Chief Commercial Officer Duncan Mckechnie sold $800K of VRTX at $519.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Duncan Mckechnie sold $1.3M of VRTX at $498.42 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Duncan Mckechnie sold $1.2M of VRTX at $475.30 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Duncan Mckechnie sold $1.2M of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Duncan Mckechnie sold $1.2M of VRTX at $489.00 — pre-scheduled 10b5-1 plan sale.